Tonyan, S.; Pospelova, M.; Krasnikova, V.; Fionik, O.; Alekseeva, T.; Samochernykh, K.; Ivanova, N.; Vavilova, T.; Vasilieva, E.; Makhanova, A.;
et al. Neurotrophin-3 (NT-3) as a Potential Biomarker of the Peripheral Nervous System Damage Following Breast Cancer Treatment. Pathophysiology 2023, 30, 110-122.
https://doi.org/10.3390/pathophysiology30020010
AMA Style
Tonyan S, Pospelova M, Krasnikova V, Fionik O, Alekseeva T, Samochernykh K, Ivanova N, Vavilova T, Vasilieva E, Makhanova A,
et al. Neurotrophin-3 (NT-3) as a Potential Biomarker of the Peripheral Nervous System Damage Following Breast Cancer Treatment. Pathophysiology. 2023; 30(2):110-122.
https://doi.org/10.3390/pathophysiology30020010
Chicago/Turabian Style
Tonyan, Samvel, Maria Pospelova, Varvara Krasnikova, Olga Fionik, Tatyana Alekseeva, Konstantin Samochernykh, Nataliya Ivanova, Tatyana Vavilova, Elena Vasilieva, Albina Makhanova,
and et al. 2023. "Neurotrophin-3 (NT-3) as a Potential Biomarker of the Peripheral Nervous System Damage Following Breast Cancer Treatment" Pathophysiology 30, no. 2: 110-122.
https://doi.org/10.3390/pathophysiology30020010
APA Style
Tonyan, S., Pospelova, M., Krasnikova, V., Fionik, O., Alekseeva, T., Samochernykh, K., Ivanova, N., Vavilova, T., Vasilieva, E., Makhanova, A., Nikolaeva, A., Bukkieva, T., Combs, S., & Shevtsov, M.
(2023). Neurotrophin-3 (NT-3) as a Potential Biomarker of the Peripheral Nervous System Damage Following Breast Cancer Treatment. Pathophysiology, 30(2), 110-122.
https://doi.org/10.3390/pathophysiology30020010
